What type of study is this?

This is a Literature Review study.

September 10, 2025Open Access

Efficacy of Low-Dose Aspirin in the Prevention of Hypertensive Complications in Pregnancy

Key Points

Low-dose aspirin may prevent hypertensive complications, highlighting its potential role in pregnancy.
Analyses show discrepancies in treatment timing and dosage, indicating the need for tailored approaches.
The review emphasizes that starting aspirin before the 16th week can effectively prevent preeclampsia.
Individualized pharmacological prevention strategies are crucial due to varying study results on aspirin use.

Abstract

Objective: To evaluate the efficacy and safety of low-dose aspirin in preventing complications related to hypertension during pregnancy. Methods: This study is a simple literature review. Articles were selected based on searches in the PubMED database using predetermined keywords and inclusion and exclusion criteria. Results: The analyzed articles presented discrepancies regarding the timing of treatment initiation and the recommended optimal dose. In this context, it is possible to conclude that aspirin in higher doses (≥ 100 mg/day), started before the 16th week of gestation, demonstrates efficacy in preventing preeclampsia. Conclusions: This study reinforces the importance of an individualized approach to the pharmacological prevention of hypertensive complications in pregnancy using low-dose aspirin, given the discrepancies found in the analyzed studies regarding dosage, timing of treatment initiation, and its effects.

Efficacy of Low-Dose Aspirin in the Prevention of Hypertensive Complications in Pregnancy

Key Points

Abstract

Cite This Study

Also Consider

Also Consider